Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A(2B) and A3 receptor subtypes

Journal of Medicinal Chemistry

Volumn 41, Issue 15, 1998, Pages 2835-2845

  Kim, Yong Chul ^a   De Zwart, Maarten ^b   Chang, Louis ^a   Moro, Stefano ^a   Von Frijtag Drabbe Künzel, Jacobien K ^b   Melman, Neli ^a   IJzerman, Ad P ^b   Jacobson, Kenneth A ^a,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b LEIDEN UNIVERSITY   (Netherlands)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 [(6 AMINOHEXANOYL)AMINO] 9 CHLORO 2 (2 FURANYL) [1,2,4]TRIAZOLO[1,5 C]QUINAZOLINE; 9 CHLORO 2 (2 FURANYL) 5 (DIPHENYLACETYLAMINO)[1,2,4]TRIAZOLO[1,5 C]QUINAZOLINE; 9 CHLORO 2 (2 FURYL) 5,6 DIHYDRO 5 IMINO 1,2,4 TRIAZOLO[2,3 C]QUINAZOLINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHO CELL; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; DRUG SYNTHESIS; HUMAN; NONHUMAN; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

EID: 0031824990     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm980094b     Document Type: Article

References (43)

1. 1-adenosine receptor antagonists. Exp. Opin. Ther. Patents 1997, 7, 419-440.
2. 2A adenosine receptor antagonists. Curr. Med. Chem. 1995, 2, 707-722.
3. Müller, C. E.; Stein, B. Adenosine receptor antagonists - structures and potential therapeutic applications. Curr. Pharm. Des. 1996, 2, 501-530.
4. 6-phenylisopropyladenosine. Naunyn-Schmiedeberg's Arch. Pharmacol. 1980, 313, 179-187.
5. 2 receptors in rat brain tissue. J. Pharmacol. Exp. Ther. 1989, 251, 888-893.
6. Fredholm, B. B. Adenosine and neuroprotection. Intl. Rev. Neurobiol. 1997, 40, 259-280.
7. Ongini, E.; Dionisotti, S.; Morelli, M.; Ferre, S.; Svenningsson, P.; Fuxe, K.; Fredholm, B. B. Neuropharmacology of the adenosine A2A receptors. Drug Dev. Res. 1996, 39, 450-460.
8. 2 adenosine receptors - their presence and neuromodulatory role in the central-nervous-system. Gen. Pharmacol. 1996, 27, 925-933.
9. Mehra, A.; Cohen, G.; Johnson, J. V.; Elkayam, U. Effect of adenosine on the renal circulation in patients with chronic heart-failure. J. Am. Coll. Cardiol. 1997, 29, 7834-7834.
10. Rongen, G. A.; Floras, J. S.; Lenders, J.; Thien, T.; Smits, P. Cardiovascular pharmacology of purines. Clin. Sci. 1997, 92, 13-24.
11. Jacobson, K. A.; Suzuki, F. Recent developments in selective agonists and antagonists acting at purine and pyrimidine receptors. Drug Dev. Res. 1996, 39, 289-300.
12. Jacobson, K. A.; von Lubitz, D. K. J. E.; Daly, J. W.; Fredholm, B. B. Adenosine receptor ligands - differences with acute versus chronic treatment. Trends Pharmacol. Sci. 1996, 17, 108-113.
13. 3 receptor stimulation reduces ischemic myocardial injury in the rabbit heart. Cardiovasc. Res. 1997, 33, 410-415.
14. 3 receptor agonists. Biochem. Biophys. Res. Commun. 1996, 221, 849-849.
15. Karton, Y.; Jiang, J. L.; Ji, X. D.; Melman, N.; Olah, M. E.; Stiles, G. L.; Jacobson, K. A. Synthesis and biological-activities of flavonoid derivatives as as adenosine receptor antagonists. J. Med. Chem. 1996, 39, 2293-2301.
16. 3 adenosine receptor antagonists. Drug. Dev. Res. 1996, 37, 131-131.
17. 3 receptors. J. Med. Chem. 1996, 39, 2980-2989.
18. 3 adenosine receptor antagonists. J. Med. Chem. 1996, 39, 4667-4675.
19. 3 adenosine receptor antagonists. J. Med. Chem. 1997, 40, 2596-2608.
20. 3 receptor subtype. J. Med. Chem. 1996, 39, 4142-4148.
21. 2B adenosine receptor gene (ADORA2B) and its pseudogene. Genomics 1995, 27, 374-376.
22. 3-selective adenosine agonists. J. Med. Chem. 1994, 37, 636-646.
23. 3 adenosine receptor. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 10365-10369.
24. 3 adenosine receptor. Mol. Pharmacol. 1994, 45, 978-982.
25. 2a adenosine receptor. J. Biol. Chem. 1995, 270, 13987-13997.
26. 1 receptor: molecular modeling and site-directed mutagenesis as a tools to identify agonist and antagonist recognition sites. J. Med. Chem. 1998, 41, 1456-1466.
27. Lin, Z.; Shenker, A.; Pearlstein, R. A model of the lutropin/ choriogonadotropin receptor: insights into the structural and functional effects of constitutively activating mutations. Protein Eng. 1997, 10, 501-510.
28. Chiota, C.; Levitt, M.; Richardson, D. Helix to helix packing in proteins. J. Mol. Biol. 1981, 145, 215-250.
29. Schertier, G. F.; Villa, C.; Henderson, R. Projection structure of rhodopsin. Nature 1993, 362, 770-772.
30. Urger, V. M.; Hargrave, P. A.; Baldwin, J. M.; Schertler, G. F. X. Arrangement of rhodopsin transmembrane α-helices. Nature 1997, 389, 203-206.
31. 2-adrenergic receptor that exploits the domain structure of G-protein-coupled receptors. J. Med. Chem. 1997, 40, 3871-3886.
32. 1 adenosine receptor. Studies on the ligand binding site by site-directed mutagenesis. J. Biol. Chem. 1992, 267, 10764-10770.
33. 2a adenosine receptor are required for ligand recognition. Mol. Pharmacol. 1996, 49, 683-691.
34. The program SYBYL 6.3 is available from TRIPOS Associates, St. Louis, MO; 1993.
35. Mohamadi, F.; Richards, N. G. J.; Guida, W. C.; Liskamp, R.; Lipton, M.; Caufield, C.; Chang, G.; Hendrickson, T.; Still, W. C. MacroModel-An Integrated Software System for Modeling Organic and Bioorganic Molecules using Molecular Mechanics. J. Comput. Chem. 1990, 11, 440-450.
36. 2Y purinoceptor using rhodopsin as template. Drug Des. Discov. 1995, 13, 133-154.
37. Kyte, J.; Doolittle, R. F. A simple method for displaying the hydrophobic character of a protein. J. Mol. Biol. 1982, 157, 105-132.
38. Weiner, S. J.; Kollman, P. A.; Nguyen, D. T.; Case, D. A. An all-atom force field for simulation of protein and nucleic acids. J. Comput. Chem. 1986, 7, 230-252.
39. English, A. R.; Girard, D.; Jasys, V. J.; Martingano, R. J.; Kellogg, M. S. Orally Effective Acid Prodrugs of the β-Lactamase Inhibitor Sulbactam. J. Med. Chem. 1990, 33, 344-347.
40. 50) of an enzyme reaction. Biochem. Pharmacol. 1973, 22, 3099-3108.
41. 1 receptor. Eur. J. Pharmacol.-Mol. Pharmacol. Sect. 1995, 290, 189-199.
42. Alexander, S. P. H.; Cooper, J.; Shine, J.; Hill, S. J. Characterization of the human brain putative A2B adenosine receptor expressed in Chinese hamster ovary (CHO.A2B.4) cells. Br. J. Pharmacol. 1996, 119, 1286-1290.
43. 2B receptors. Pharmacol. Rev. 1997, 49, 381-402.